Forte Biosciences, Inc.
FBRX
Revenue
9.00k
0.000.00%
3 Months ChangeAssets
26.08M
▼-5.94M▼-18.55%
3 Months ChangeLiabilities
16.55M
▼-762.00k▼-4.40%
3 Months ChangeFree Cash Flow
-6.67M
▲11.14M▲62.54%
60 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-20
Form 8-K
ID: 0001193125-24-222962
2024-08-30
Form 8-K
ID: 0001193125-24-211066
2024-08-22
Form 8-K
ID: 0001193125-24-205350
2024-08-14
Form 8-K
ID: 0001193125-24-200673
2024-08-14
Form 10-Q
ID: 0000950170-24-096988
2024-06-14
Form 8-K
ID: 0001193125-24-161592
2024-05-13
Form 10-Q
ID: 0000950170-24-058669
2024-05-13
Form 8-K
ID: 0001193125-24-137210
2024-03-18
Form 8-K
ID: 0001193125-24-070158
2023-12-08
Form 8-K
ID: 0001193125-23-291670